While proponents of direct-to-consumer drug advertising tout them as vehicles for patient empowerment, critics point to their influence on unsound prescribing and the medicalization of human experience.
The guidelines for patients’ eligibility for bariatric surgery have not changed since 1991, although recent data suggest there may be indications for broadening application of the surgery.